A Study of GLB-001 in Patients With Myeloid Malignancies

NCT06378437 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera
Essential Thrombocythemia
Myelofibrosis
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Myeloid Malignancy

Interventions

DRUG: GLB-001

Sponsor

Hangzhou GluBio Pharmaceutical Co., Ltd.